Synthesis, Structural Characterization and Anticancer Activity of New 5-Trifluoromethyl-2-thioxo-thiazolo[4,5-
anticancer activity
thiazolo[4,5-d]pyrimidines
trifluoromethyl derivatives
Journal
Pharmaceuticals (Basel, Switzerland)
ISSN: 1424-8247
Titre abrégé: Pharmaceuticals (Basel)
Pays: Switzerland
ID NLM: 101238453
Informations de publication
Date de publication:
13 Jan 2022
13 Jan 2022
Historique:
received:
02
12
2021
revised:
29
12
2021
accepted:
10
01
2022
entrez:
21
1
2022
pubmed:
22
1
2022
medline:
22
1
2022
Statut:
epublish
Résumé
Thiazolo[4,5-
Identifiants
pubmed: 35056147
pii: ph15010092
doi: 10.3390/ph15010092
pmc: PMC8778818
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Med Chem Res. 2013 May;22(5):2376-2384
pubmed: 23543906
J Med Chem. 2008 Aug 14;51(15):4359-69
pubmed: 18570365
Eur J Med Chem. 2016 May 4;113:198-213
pubmed: 26942627
Arzneimittelforschung. 1977;27(9):1652-5
pubmed: 579132
Chembiochem. 2004 May 3;5(5):637-43
pubmed: 15122635
Lancet Oncol. 2021 Apr;22(4):489-498
pubmed: 33794206
Annu Rev Pharmacol Toxicol. 2001;41:443-70
pubmed: 11264465
Acta Crystallogr C Struct Chem. 2015 Jan;71(Pt 1):3-8
pubmed: 25567568
Semin Oncol. 1992 Dec;19(6):622-38
pubmed: 1462164
Arch Pharm (Weinheim). 2003 Jul;336(4-5):216-25
pubmed: 12916055
Cancer Cell Int. 2017 Jan 3;17:4
pubmed: 28053599
J Enzyme Inhib Med Chem. 2007 Oct;22(5):527-40
pubmed: 18035820
Arzneimittelforschung. 2008;58(10):521-8
pubmed: 19025063
ChemMedChem. 2018 Nov 6;13(21):2271-2280
pubmed: 30407750
Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):3-26
pubmed: 11259830
Cancer Res. 1988 Feb 1;48(3):589-601
pubmed: 3335022
Prog Med Chem. 2015;54:65-133
pubmed: 25727703
Nat Rev Cancer. 2006 Oct;6(10):813-23
pubmed: 16990858
Chem Soc Rev. 2008 Feb;37(2):320-30
pubmed: 18197348
Science. 2007 Sep 28;317(5846):1881-6
pubmed: 17901324
Endocr Relat Cancer. 2014 Aug;21(4):T105-18
pubmed: 24639562
Acta Crystallogr A. 2008 Jan;64(Pt 1):112-22
pubmed: 18156677
Cancer Res. 2004 Oct 1;64(19):7099-109
pubmed: 15466206